Benralizumab after sub-optimal response to mepolizumab in severe eosinophilic asthma

Kavanagh Joanne E.; Hearn Andrew P.; DAncona Grainne; Dhariwal Jaideep; Roxas Cris; Green Linda; Thomson Louise; Fernandes Mariana; Kent Brian D.; Nanzer Alexandra M.; Jackson David J.

首页> 外文期刊>Allergy >Benralizumab after sub-optimal response to mepolizumab in severe eosinophilic asthma

【24h】

Benralizumab after sub-optimal response to mepolizumab in severe eosinophilic asthma

机译：在严重的嗜酸性哮喘中对mepolizumab的次良响应后的Benralizumab

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Allergy》 |2021年第6期|共4页
作者
Kavanagh Joanne E.; Hearn Andrew P.; DAncona Grainne; Dhariwal Jaideep; Roxas Cris; Green Linda; Thomson Louise; Fernandes Mariana; Kent Brian D.; Nanzer Alexandra M.; Jackson David J.;
展开▼
作者单位

Guys &

St Thomas NHS Trust Guys Hosp Guys Severe Asthma Ctr London SE1 9RT England;

Guys &

St Thomas NHS Trust Guys Hosp Guys Severe Asthma Ctr London SE1 9RT England;

Guys &

St Thomas NHS Trust Guys Hosp Guys Severe Asthma Ctr London SE1 9RT England;

Guys &

St Thomas NHS Trust Guys Hosp Guys Severe Asthma Ctr London SE1 9RT England;

Guys &

St Thomas NHS Trust Guys Hosp Guys Severe Asthma Ctr London SE1 9RT England;

Guys &

St Thomas NHS Trust Guys Hosp Guys Severe Asthma Ctr London SE1 9RT England;

Guys &

St Thomas NHS Trust Guys Hosp Guys Severe Asthma Ctr London SE1 9RT England;

Guys &

St Thomas NHS Trust Guys Hosp Guys Severe Asthma Ctr London SE1 9RT England;

St James Hosp Dept Resp Med Dublin Ireland;

Guys &

St Thomas NHS Trust Guys Hosp Guys Severe Asthma Ctr London SE1 9RT England;

Guys &

St Thomas NHS Trust Guys Hosp Guys Severe Asthma Ctr London SE1 9RT England;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类医学免疫学;
关键词

相似文献

外文文献
中文文献
专利

1. Metabolomic Analysis of Serum Glycerophospholipid Levels in Eosinophilic and Neutrophilic Asthma [J] . GAI Xiao Yan, ZHANG Li Jiao, CHANG Chun, 生物医学与环境科学（英文版） . 2019,第002期
2. Eosinophilic gastroenteritis associated with allergic asthma and atopic eczema [J] . Bora Akta(s), (S)ahin (C)oban, Akif Alt(l)nba(s), 中华医学杂志（英文版） . 2014,第001期
3. CCR3 monoclonal antibody inhibits airway eosinophilic inflammation and mucus overproduction in a mouse model of asthma [J] . Hua-hao SHEN, Feng XU, Gen-sheng ZHANG, 中国药理学报：英文版 . 2006,第012期
4. Efficacy and safety of treatment with biologicals (benralizumab, dupilumab, mepolizumab, omalizumab and reslizumab) for severe eosinophilic asthma. A systematic review for the EAACI Guidelines ‐ recommendations on the use of biologicals in severe asthma [J] . Allergy . 2020,第5期

机译：生物学（Benralizumab，Dupilumab，Mepolizumab，Omalizumab和Reslizumab）治疗的疗效和安全性对严重的嗜酸性哮喘。对EAACI指南的系统审查 - 关于在严重哮喘中使用生物学的建议
5. Ceruloplasmin and oxidative stress in severe eosinophilic asthma patients treated with Mepolizumab and Benralizumab [J] . Landi Claudia, Cameli Paolo, Vantaggiato Lorenza, Biochimica et biophysica acta: BBA: International journal of biochemistry, biophysics and molecular biololgy. Proteins and Proteomics . 2021,第2期

机译：用Mepolizumab和Benralizumab治疗的严重嗜酸性哮喘患者的刺激素和氧化应激
6. Antibodies targeting the interleukin-5 signaling pathway used as add-on therapy for patients with severe eosinophilic asthma: a review of the mechanism of action, efficacy, and safety of the subcutaneously administered agents, mepolizumab and benralizumab [J] . Hillas Georgios, Fouka Evangelia, Papaioannou Andriana I. Expert review of respiratory medicine . 2020,第1a6期

机译：靶向白细胞介素-5信号传导途径的抗体用作严重嗜酸性哮喘患者的添加疗法：对皮下给药剂，甲醇嗪和北珠三胞烃的疗法，疗效和安全机制进行审查
7. Eosinophilic Inflammation in Asthma [C] . M. Nagata Asia Pacific Congress of Allergology and Clinical Immunology . 2004

机译：哮喘中的嗜酸性炎症
8. The impact of severe housing stress on child asthma control and pediatric asthma caregiver quality of life (PACQOL). [D] . Kishore, Nina. 2014

机译：严重的住房压力对儿童哮喘控制和小儿哮喘护理人员的生活质量（PACQOL）的影响。
9. Real-World Multicenter Experience with Mepolizumab and Benralizumab in the Treatment of Uncontrolled Severe Eosinophilic Asthma Over 12 Months [O] . Moritz Z Kayser, Nora Drick, Katrin Milger, 2021

机译：与Mepolizumab和Benralizumab的现实世界多中心体验治疗12个月内不受控制的严重嗜酸性哮喘
10. Benralizumab after sub‐optimal response to mepolizumab in severe eosinophilic asthma [O] . Joanne E. Kavanagh, Andrew P. Hearn, Grainne d’Ancona, 2020

机译：在严重嗜酸性哮喘中对mepolizumab的次良响应后的Benralizumab
11. Pilot Program: NRC (U.S. Nuclear Regulatory Commission) Severe Reactor Accident Incident Response Training Manual. Volume 2. Severe Reactor Accident Overview [R] . McKenna, T. J., Martin, J. A., Miller, C. W., 1987

机译：试点计划：NRC（美国核管理委员会）严重反应堆事故应急培训手册。第2卷。严重的反应堆事故概述

Benralizumab after sub-optimal response to mepolizumab in severe eosinophilic asthma

著录项

相似文献

相关主题

期刊订阅